We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

3rd Circ. Already OK'd Lipitor State Claims, Health Plans Say

Law360 (May 15, 2018, 6:43 PM EDT) -- The Third Circuit has already cleared a group of health plans that paid for the blockbuster cholesterol medication Lipitor to bring antitrust litigation against Pfizer Inc. and Ranbaxy Inc. based on various state laws, so the drugmakers' bid to dismiss the claims is fruitless, the plans told a New Jersey federal court Monday.

The drugmakers' April motion to dismiss had argued the case was preempted by federal patent law. However, during an earlier appeal, the Third Circuit refused to hand the reverse payment case over to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.